GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Skinvisible Inc (OTCPK:SKVI) » Definitions » EBIT

Skinvisible (Skinvisible) EBIT : $-0.49 Mil (TTM As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Skinvisible EBIT?

Skinvisible's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-0.12 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.49 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Skinvisible's annualized ROC % for the quarter that ended in Mar. 2024 was -62.28%. Skinvisible's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Skinvisible's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -7.37%.


Skinvisible EBIT Historical Data

The historical data trend for Skinvisible's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skinvisible EBIT Chart

Skinvisible Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.70 -0.25 0.14 -0.06 -0.50

Skinvisible Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.11 -0.12 -0.14 -0.12

Competitive Comparison of Skinvisible's EBIT

For the Household & Personal Products subindustry, Skinvisible's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skinvisible's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Skinvisible's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Skinvisible's EV-to-EBIT falls into.



Skinvisible EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Skinvisible  (OTCPK:SKVI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Skinvisible's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-0.492 * ( 1 - 0% )/( (0.626 + 0.954)/ 2 )
=-0.492/0.79
=-62.28 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Skinvisible's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.496/( ( (0 + max(-3.02, 0)) + (0 + max(-3.276, 0)) )/ 2 )
=-0.496/( ( 0 + 0 )/ 2 )
=-0.496/0
= %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.005 + 0 + 0.007) - (3.014 + 0 + 0.018)
=-3.02

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.005 + 0 + 0) - (3.262 + 0 + 0.019)
=-3.276

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Skinvisible's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=-0.489/6.636
=-7.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Skinvisible EBIT Related Terms

Thank you for viewing the detailed overview of Skinvisible's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Skinvisible (Skinvisible) Business Description

Traded in Other Exchanges
N/A
Address
6320 South Sandhill Road, Suite 10, Las Vegas, NV, USA, 89120
Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active.
Executives
St James David M director 3395 S. JONES BLVD., #169, LAS VEGAS NV 89146
Doreen Mcmorran 10 percent owner 6320 S. SANDHILL RD UNIT 10, LAS VEGAS NV 89120
Brian Piwek director 9014 GLENEAGLE DRIVE, BLAINE WA 98230
E Greg Mccartney director #307-15338 18TH AVENUE, SURREY BC A1 V4A 1W8
Jost Steinbruchel director 7, RUE DES BATTOIRS, POBOX #214, 1211 GENEVA 4 V8 000000
Robert F Lutz director, 10 percent owner
Terry Howlett director, 10 percent owner, officer: President & Chief Exec.Officer 6320 S. SANDHILL ROAD, SUITE #10, LAS VEGAS NV 89120
Skinvisible Inc director, 10 percent owner, officer: President 6320 S SANDHILL ROAD, SUITE 10, LAS VEGAS NV 89120
Lutz Family Trust 10 percent owner 8322 WEST TONTO LANE, PEORIA AZ 85382